E. Van Cutsem Et Al. , "Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study," ANNALS OF ONCOLOGY , vol.26, no.1, pp.149-156, 2015
Van Cutsem, E. Et Al. 2015. Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study. ANNALS OF ONCOLOGY , vol.26, no.1 , 149-156.
Van Cutsem, E., Boni, C., Tabernero, J., Massuti, B., Middleton, G., Dane, F., ... Reichardt, P.(2015). Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study. ANNALS OF ONCOLOGY , vol.26, no.1, 149-156.
Van Cutsem, E. Et Al. "Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study," ANNALS OF ONCOLOGY , vol.26, no.1, 149-156, 2015
Van Cutsem, E. V. Et Al. "Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study." ANNALS OF ONCOLOGY , vol.26, no.1, pp.149-156, 2015
Van Cutsem, E. Et Al. (2015) . "Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study." ANNALS OF ONCOLOGY , vol.26, no.1, pp.149-156.
@article{article, author={E. Van Cutsem Et Al. }, title={Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study}, journal={ANNALS OF ONCOLOGY}, year=2015, pages={149-156} }